JLL Income Property Trust CEO Acquires Shares in Company
C. Allan Swaringen, CEO of JLL Income Property Trust, purchases shares, signaling confidence in the company's future amidst industry scrutiny.
JLL Income Property Trust reports director stock transaction
JLL Income Property Trust, Inc. discloses recent stock transactions by director Tamara D. Fischer, reflecting ongoing investment in the real estate sector.
Hurd Laurel sells 7,000 shares of Interface Inc stock
Hurd Laurel, President and CEO of Interface Inc, sells 7,000 shares as part of a trading plan, reflecting strategic financial planning.
Denien Mark A acquires shares through deferred stock units
Mark A. Denien reports acquisition of shares via deferred stock units, reflecting ongoing compensation strategies at JLL Income Property Trust.
EpicQuest Education Group's Agreement with Miami University Ends
EpicQuest Education Group faces a major shift as Miami University terminates its recruitment agreement, impacting future operations and partnerships.
Seritage Growth Properties Declares Cash Dividend for Preferred Shares
Seritage Growth Properties announces a cash dividend of $0.4375 per share on its 7.00% Series A Cumulative Redeemable Preferred Shares, payable January 15, 2027.
JPMorgan Trust I Updates Prospectus for Small Cap Equity Fund
JPMorgan Trust I has filed a new prospectus for its Small Cap Equity Fund, detailing investment strategies and fee structures.
JPMorgan Trust I updates prospectus for U.S. Equity Fund
JPMorgan Trust I has filed an updated prospectus for its U.S. Equity Fund, detailing fees and investment strategies, emphasizing transparency in the investment sector.
Alland Leila Files Form 3 as Chief Medical Officer
Alland Leila has filed a Form 3, confirming her role as Chief Medical Officer at Cardiff Oncology, Inc., impacting the biological products sector.
Opus Genetics COO sells shares to meet tax obligations
Opus Genetics COO Joseph K. Schachle sold shares to cover tax obligations from restricted stock units, highlighting ongoing management in the pharmaceutical sector.
Nomura ETF Trust II Files Post-Effective Amendment for ETF
Nomura ETF Trust II files a post-effective amendment to set a new effective date for the Nomura Japan Equity ETF, reflecting ongoing market adaptations.
JPMorgan Trust I Files New Prospectus for Mid Cap Equity Fund
JPMorgan Trust I updates its prospectus for the Mid Cap Equity Fund, detailing fees and investment goals, impacting investors and the mutual fund industry.
Principal Exchange-Traded Funds Registers Principal Growth ETF
Principal Exchange-Traded Funds has registered a new class of securities, the Principal Growth ETF, with the SEC, expanding its investment offerings.
JPMorgan Trust I updates prospectus for Small Cap Blend Fund
JPMorgan Trust I updates its Small Cap Blend Fund prospectus, detailing investment strategies and fees effective November 1, 2026.
Opus Genetics President Sells Shares Amid Tax Obligations
Opus Genetics, Inc. reports stock sales by President Benjamin R. Yerxa, highlighting company equity management and tax obligations in the pharmaceutical industry.
JPMorgan Trust I updates prospectus for Hedged Equity Fund
JPMorgan Trust I updates its prospectus for the Hedged Equity Fund, detailing investment strategies and fees, impacting investors and the investment industry.
Richard Fairey Discloses Beneficial Ownership in Georgia Banking
Richard Fairey files initial ownership statement, revealing significant holdings in Georgia Banking Company, emphasizing transparency in the banking sector.
LGAM Private Credit LLC Issues Regulation FD Disclosure
LGAM Private Credit LLC files an 8-K report revealing a Regulation FD disclosure, emphasizing transparency in communications with stakeholders.
Sumisho Air Lease Corp's CCO David Swan Resigns Immediately
Sumisho Air Lease Corp announces the resignation of David Swan as Chief Commercial Officer and director, effective immediately.
Cooper Companies Announces Leadership Transition, New Chair
Cooper Companies transitions leadership with Albert White III's resignation as CEO and Walter Rosebrough's appointment as Executive Chair.